Bank of New York Mellon Corp - CADENCE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 100 filers reported holding CADENCE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$2,823,000
-32.4%
311,910
-52.9%
0.00%0.0%
Q3 2013$4,174,000
+111.3%
662,880
+128.9%
0.00%0.0%
Q2 2013$1,975,000–289,572–0.00%–
 Download
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q4 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders